Micro-Cap Pharmaceutical Stocks

U.S. Exchanges

List of Publicly Traded Micro-Cap Pharmaceutical Companies Listed on Major U.S. Exchanges

This list includes very small-sized pharmaceutical companies with market capitalizations under 300 million dollars. In the world of investing these are referred to as micro-cap stocks. We update this page at the start of every month so it is possible that during the course of a month a company’s market cap might go above 300 million. We have also separated out companies with a market cap less than 50 million dollars and these companies can be found below the micro-cap stock list.

Additional pharmaceutical companies can be found in the following sections:

List of Pharmaceutical Companies

Large-Cap Pharmaceuticals

Mid-Cap Pharmaceuticals

Small-Cap Pharmaceuticals

Biopharmaceutical companies are generally not included on this list of companies and can be found in our Biotech section. In parentheses you will find a short description or examples of areas of focus listed for the company.

A comparison widget that shows trend, earnings per share (EPS), P/E ratio and beta for each of the companies on this list can be accessed through the link below.

Micro-Cap Pharmaceutical Industry Comparison Widget

IPOs in 2016

Moleculin Biotech, Inc. (MBRX) (IPO June 2, 2016: clinical stage pharmaceutical company, anticancer drug candidates)

Select the company’s link to access charts, news links and company website and social media information.

Pharmaceuticals: Micro-Cap Stocks

Concordia International Corp. (CXRX) (Canada: ADHD, cancer and asthma)

Corium International, Inc. (CORI) (Transdermal and transmucosal delivery systems; Alzheimer’s disease; partners include Procter & Gamble)

Cumberland Pharmaceuticals Inc. (CPIX) (Acetaminophen poisoning; pain and fever; prescription laxative; hyponatremia; H. pylori and duodenal ulcer disease; kidney failure)

Merus Labs International Inc. (MSLI) (Canada:  specialty pharmaceutical company)

VTV Therapeutics Inc. (VTVT) (IPO in July 2015: Clinical stage pharmaceutical company:  cancer, central nervous system disorders, diabetes and metabolic disorders, inflammation)


Neos Therapeutics, Inc. (NEOS) (IPO in July 2015: Attention deficit hyperactivity disorder)

Animal Health

Aratana Therapeutics, Inc. (PETX) (Pet therapeutics company)


Tetraphase Pharmaceuticals, Inc. (TTPH) (Antibiotics platform based on the tetracycline core)


ESSA Pharma Inc. (EPIX) (Canada: small molecule drugs for the treatment of prostate cancer)

Oasmia Pharmaceutical AB (OASM) (IPO in October 2015, Sweden: Human and animal oncology)

Drug Delivery

Intellipharmaceutics International Inc. (IPCI) (Canada: controlled-release and targeted-release oral solid dosage drugs)

Oramed Pharmaceuticals Inc. (ORMP) (Israel: platform for oral delivery of drugs)

SteadyMed Ltd (STDY) (IPO in March 2015: Specialty pharmaceutical company; pump delivery products for injectable drugs)


Alimera Sciences, Inc. (ALIM) (Ophthalmic pharmaceuticals)

Fungal Infections

SCYNEXIS, Inc. (SCYX) (Serious and life-threatening invasive fungal infections)


Cardiome Pharma Corporation (CRME) (Canada: heart disease)


Esperion Therapeutics, Inc. (ESPR) (LDL-C lowering therapies)


AcelRx Pharmaceuticals, Inc. (ACRX) (Therapies for the treatment of acute pain)

Aralez Pharmaceuticals Inc. (ARLZ) (Specialty pharmaceutical company: cardiovascular, pain management)

BioDelivery Sciences International, Inc. (BDSI) (Pain management and addiction medicine)

Egalet Corporation (EGLT) (Medicines for patients with moderate to severe pain)

KemPharm Inc. (KMPH) (IPO in April 2015: Specialty pharmaceutical company: prodrugs that are designed to improve one or more attributes of currently approved drugs; pipeline includes pain, ADHD and CNS indications)

Recro Pharma, Inc. (REPH) (Non-opioid therapeutics for the treatment of acute post-operative pain)


Adamis Pharmaceuticals Corporation (ADMP) (Respiratory disease, allergy)


Lipocine Inc. (LPCN) (Testosterone replacement)

Women’s Health

Agile Therapeutics, Inc. (AGRX) (Contraceptive products)

Juniper Pharmaceuticals, Inc. (JNP) (Specialty pharmaceutical company: therapeutics that address unmet medical needs)

Pharmaceuticals: Nano-Cap Stocks


Neothetics, Inc. (NEOT) (Therapeutics for the aesthetic market; fat reduction and body contouring)


Immune Pharmaceuticals Inc. (IMNP) (Antibody therapeutics: inflammatory diseases and cancer)


Delcath Systems, Inc. (DCTH) (Specialty pharmaceutical and medical device company: cancer)

Midatech Pharma plc (MTP) (Oncology treatment and supportive care products)

Moleculin Biotech, Inc. (MBRX) (IPO June 2, 2016: clinical stage pharmaceutical company, anticancer drug candidates)

Consumer Health

Biostar Pharmaceuticals, Inc. (BSPM) (China: manufacturer of pharmaceutical and health supplement products; over-the-counter medicine for chronic hepatitis B)

ProPhase Labs, Inc. (PRPH) (Over-the-counter cold remedy, consumer health products, natural base health products, supplements, cosmeceuticals)

Drug Delivery

Acura Pharmaceuticals, Inc. (ACUR) (Tamper-resistant products to combat medication abuse)

Zosano Pharma Corporation (ZSAN) (IPO in January 2015: Drug delivery: osteoporosis, hypoglycemia and migraine)


Eyegate Pharmaceuticals, Inc.  (EYEG) (Specialty pharmaceutical and drug delivery company: therapies and drug delivery technologies)


Evoke Pharma, Inc. (EVOK) (Drugs to treat gastrointestinal disorders and diseases)

Ritter Pharmaceuticals Inc. (RTTR) (IPO in June 2015: Specialty pharmaceutical company: gastrointestinal diseases)


Aoxing Pharmaceutical Company, Inc. (AXN) (China: narcotics and pain management products)

Pernix Therapeutics Holdings, Inc. (PTX) (Specialty, primary care and generic medicines; neurology and pain management)


Aradigm Corporation (ARDM) (Severe respiratory disease)

Nivalis Therapeutics Inc. (NVLS) (IPO in June 2015: therapies designed to treat cystic fibrosis)


Dipexium Pharmaceuticals, Inc. (DPRX) (Topical antibiotic peptide used in the treatment of mild and moderate skin and skin structure infections)

Sonoma Pharmaceuticals, Inc. (SNOA) (Specialty pharmaceuticals: wound management, dermatology, women’s health and animal health)

Women’s Health

BioPharmX Corporation (BPMX) (Specialty pharmaceuticals: women’s health and dermatology)

Related Links:

Publicly Traded Companies by Sector and Industry

List of Pharmaceutical ETFs

List of Healthcare Companies

Micro-Cap Stocks